ABM Investama Tbk PT
F:0A1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ABM Investama Tbk PT
F:0A1
|
ID |
|
Novabase SGPS SA
F:NVQ
|
PT |
|
G
|
Gaztransport et Technigaz SA
F:9TG
|
FR |
|
I
|
Inogen Inc
F:6IO
|
US |
|
T
|
Tenax Therapeutics Inc
F:YBOC
|
US |
|
B
|
Briacell Therapeutics Corp
TSX:BCT
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0A1's stock price target?
Not Available
0A1 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for ABM Investama Tbk PT?
Projected CAGR
-2%
Over the last 14 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 11 years is -2%.
What is the Operating Income forecast for ABM Investama Tbk PT?
Projected CAGR
-3%
Over the last 14 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 11 years is -3%.
What is the Net Income forecast for ABM Investama Tbk PT?
Projected CAGR
-25%
Over the last 14 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 11 years is -25%.
